Medincell SA
PAR:MEDCL

Watchlist Manager

Medincell SA

PAR:MEDCL

Watchlist

Dividends

Discount Rate

Price: 17.82 EUR -0.45% Market Closed

Market Cap: 518.1m EUR

Have any thoughts about
Medincell SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 17.82 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MEDCL Alert

Medincell SA

17.82

-0.08 (-0.45%)

52 Week Range	5.92 18.64
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Medincell SA

What unique competitive advantages
does Medincell SA hold over its rivals?

What risks and challenges
does Medincell SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Medincell SA.

What unique competitive advantages
does Medincell SA hold over its rivals?

What risks and challenges
does Medincell SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medincell SA.

Provide P/S
for Medincell SA.

Provide P/E
for Medincell SA.

Provide P/OCF
for Medincell SA.

Provide P/FCFE
for Medincell SA.

Provide P/B
for Medincell SA.

Provide EV/S
for Medincell SA.

Provide EV/GP
for Medincell SA.

Provide EV/EBITDA
for Medincell SA.

Provide EV/EBIT
for Medincell SA.

Provide EV/OCF
for Medincell SA.

Provide EV/FCFF
for Medincell SA.

Provide EV/IC
for Medincell SA.

Show me price targets
for Medincell SA made by professional analysts.

What are the Revenue projections
for Medincell SA?

How accurate were the past Revenue estimates
for Medincell SA?

What are the Net Income projections
for Medincell SA?

How accurate were the past Net Income estimates
for Medincell SA?

What are the EPS projections
for Medincell SA?

How accurate were the past EPS estimates
for Medincell SA?

What are the EBIT projections
for Medincell SA?

How accurate were the past EBIT estimates
for Medincell SA?

Compare the revenue forecasts
for Medincell SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medincell SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medincell SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medincell SA compared to its peers.

Compare the P/E ratios
of Medincell SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Medincell SA with its peers.

Analyze the financial leverage
of Medincell SA compared to its main competitors.

Show all profitability ratios
for Medincell SA.

Provide ROE
for Medincell SA.

Provide ROA
for Medincell SA.

Provide ROIC
for Medincell SA.

Provide ROCE
for Medincell SA.

Provide Gross Margin
for Medincell SA.

Provide Operating Margin
for Medincell SA.

Provide Net Margin
for Medincell SA.

Provide FCF Margin
for Medincell SA.

Show all solvency ratios
for Medincell SA.

Provide D/E Ratio
for Medincell SA.

Provide D/A Ratio
for Medincell SA.

Provide Interest Coverage Ratio
for Medincell SA.

Provide Altman Z-Score Ratio
for Medincell SA.

Provide Quick Ratio
for Medincell SA.

Provide Current Ratio
for Medincell SA.

Provide Cash Ratio
for Medincell SA.

What is the historical Revenue growth
over the last 5 years for Medincell SA?

What is the historical Net Income growth
over the last 5 years for Medincell SA?

What is the current Free Cash Flow
of Medincell SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medincell SA.

Section:

Wall Street
Price Targets

MEDCL Price Targets Summary
Medincell SA

Wall Street analysts forecast MEDCL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDCL is 21.93 EUR with a low forecast of 18.48 EUR and a high forecast of 25.2 EUR.

MEDCL Lowest Forecast

Wall Street Target

18.48 EUR

4% Upside

MEDCL Average Forecast

Wall Street Target

21.93 EUR

23% Upside

MEDCL Highest Forecast

Wall Street Target

25.2 EUR

41% Upside

Lowest

Price Target

18.48 EUR

4% Upside

Average

Price Target

21.93 EUR

23% Upside

Highest

Price Target

25.2 EUR

41% Upside

Medincell SA Competitors:
Price Targets

GLAND

Gland Pharma Ltd

6% Upside

MRK

Merck & Co Inc

42% Upside

600267

Zhejiang Hisun Pharmaceutical Co Ltd

24% Downside

NEULANDLAB

Neuland Laboratories Ltd

17% Downside

GLAND

Gland Pharma Ltd

6% Upside

MRK

Merck & Co Inc

42% Upside

600267

Zhejiang Hisun Pharmaceutical Co Ltd

24% Downside

NEULANDLAB

Neuland Laboratories Ltd

17% Downside

INDOCO

Indoco Remedies Ltd

17% Upside

GHRS

GH Research PLC

252% Upside

4506

Sumitomo Pharma Co Ltd

7% Downside

603566

Pulike Biological Engineering Inc

13% Upside

Revenue
Forecast

Revenue Estimate
Medincell SA

For the last 5 years the compound annual growth rate for Medincell SA's revenue is 44%. The projected CAGR for the next 3 years is 130%.

44%

Past Growth

130%

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medincell SA

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medincell SA

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

What is MEDCL's stock price target?

Price Target
21.93 EUR

According to Wall Street analysts, the average 1-year price target for MEDCL is 21.93 EUR with a low forecast of 18.48 EUR and a high forecast of 25.2 EUR.

What is Medincell SA's Revenue forecast?

Projected CAGR
130%

For the last 5 years the compound annual growth rate for Medincell SA's revenue is 44%. The projected CAGR for the next 3 years is 130%.

Medincell SA
PAR:MEDCL